Back to Trades
Behbahani Ali
InsiderCIK 0001613867
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 16
- Buy transactions
- 0
- Sell transactions
- 6
- Companies
- 9
- Active
- 2025–2026
Behbahani Ali has filed 16 SEC reports (2025–2026), spread across 9 companies, totaling $6.0M in disclosed volume. Weighing $0 bought versus $255.6K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Korro Bio, Inc. (KRRO)
2 filings
$2.5M
Arcellx, Inc. (ACLX)
2 filings
$1.4M
CRISPR Therapeutics AG (CRSP)
1 filing
$673.9K
Monte Rosa Therapeutics, Inc. (GLUE)
2 filings
$441.2K
SpyGlass Pharma, Inc. (SGP)
2 filings
$438.4K
Adaptimmune Therapeutics PLC (ADAP)
1 filing
$229.2K
Black Diamond Therapeutics, Inc. (BDTX)
4 filings
$112.5K
NeueHealth, Inc. (NEUE)
1 filing
$106.6K
Nkarta, Inc. (NKTX)
1 filing
$91.0K
Trading History
16 loaded
| Jul 6 | GLUE Monte Rosa Therapeutics, Inc. | Behbahani Ali | Insider | Other | $0 |
| Jun 29 | BDTX Black Diamond Therapeutics, Inc. | Behbahani Ali | Insider | Award | $68.4K |
| Jun 22 | BDTX Black Diamond Therapeutics, Inc. | Behbahani Ali | Insider | Grant | $14.9K |
| Jun 12 | GLUE Monte Rosa Therapeutics, Inc. | Behbahani Ali | Insider | Award | $441.2K |
| Jun 11 | KRRO Korro Bio, Inc. | Behbahani Ali | Insider | Award | $155.4K |
| Jun 11 | NKTX Nkarta, Inc. | Behbahani Ali | Insider | Award | $91.0K |
| Jun 9 | CRSP CRISPR Therapeutics AG | Behbahani Ali | Insider | Award | $673.9K |
| Apr 28 | ACLX Arcellx, Inc. | Behbahani Ali | Insider | Disposed | $1.4M |
| Mar 20 | BDTX Black Diamond Therapeutics, Inc. | Behbahani Ali | Insider | Grant | $14.9K |
| Mar 12 | KRRO Korro Bio, Inc. | Behbahani Ali | Insider | Grant | $2.3M |
| Feb 9 | SGP SpyGlass Pharma, Inc. | Behbahani Ali | Insider | Award | $438.4K |
| Feb 5 | SGP SpyGlass Pharma, Inc. | Behbahani Ali | Insider | Other | $0 |
| Oct 6 | NEUE NeueHealth, Inc. | Behbahani Ali | Insider | Sell | $26.4K |
| Sep 22 | BDTX Black Diamond Therapeutics, Inc. | Behbahani Ali | Insider | Grant | $14.4K |
| Aug 19 | ADAP Adaptimmune Therapeutics PLC | Behbahani Ali | Insider | Sell | $229.2K |
| Aug 14 | ACLX Arcellx, Inc. | Behbahani Ali | Insider | Other | $0 |
16 filings